Xiaflex collagenase clostridium histolyticum: Phase III started

Last month, Auxilium Pharmaceuticals began a pair of 52-week, double-blind, placebo-controlled, international Phase III trials in 300 patients each to evaluate twice-weekly Xiaflex every 6 weeks for u...